OUR TEAM

PharPoint Research works as an extension of your internal team, providing expertise and personalized guidance to ensure your study is completed with impeccable monitoring, data collection, and analysis. PharPoint’s project teams fully participate in meetings and quickly respond to questions that may arise in between scheduled discussions. With each project, we carefully select and assemble team members with the experience to fit the requirements of your study. However, our teams do not work alone. We use the expertise of all employees, including our founders, to provide on-time, quality deliverables. This approach allows us to pull from the broad experience of all team members, giving us the ability to anticipate issues, provide solutions, and stay ahead of deadlines.
Arthur L. Holmes
President and CEO
Mr. Holmes has acquired over twenty six years of experience in the pharmaceutical industry, including extensive experience in pharmaceutical consulting and contract services.
Prior to PharPoint, he founded Databasics Consulting, Inc., a company specializing in systems implementation and validation for pharmaceutical and biotechnology clients. Mr. Holmes has also held management positions at Quintiles Transnational Corp. and PharmaResearch Inc, subsequently known as Kendle International. In his capacity with these companies, he provided leadership in both technical and operational strategies.
Audra G. McRae
Chief Operating Officer
Ms. McRae’s twenty four years of experience in clinical research include both laboratory research and various aspects of clinical trial oversight.
In her extensive CRO industry experience, Ms. McRae has directed large international data management departments, providing integration and process development management for three corporate mergers. Active in industry organizations, Ms. McRae is a member of the Society for Clinical Data Management and served on the Board of Directors for the society from 2003 to 2005.
Jennifer A. Elder, PhD
Chief Scientific Officer
Dr. Elder has performed statistical analyses for clinical trials for eighteen years, with fourteen of those years being in the CRO industry.
Dr. Elder served as the lead statistician on pivotal studies for two novel compounds in a new class of antiretroviral medications in indications for the treatment of HIV and viral hepatitis. She participated in the completion of several NDA, MAA, sNDA, and IND applications and provided strategic consulting, clinical program development planning, and statistical analysis oversight for over seventy-five projects. Additionally, her experience includes providing statistical support for several pharmaceutical industry sponsored pregnancy registries and phase I through IV clinical trials. Prior to her CRO experience, Dr. Elder was an Assistant Professor of Biostatistics and a statistical consultant at the University of North Carolina at Wilmington where she maintains an adjunct affiliation. Dr. Elder has participated in the authorship of many presentations and has been an invited speaker at several industry conferences.
Jennifer L. Bruce
Director of Clinical Operations
Jenny Bruce of PharPoint
Jenny has over 20 years of academic/industry experience, involving preclinical pharmacology and clinical research. Her clinical experience includes work within biotech, large pharma and CRO environments.
In the clinical arena, her work has included the implementation and management of global Phase I – IV studies, particularly large pivotal Phase II/III studies. She has functioned as Assistant and Associate Director of Clinical Research and Director of Project Management where she was responsible for the operational success of large global, multidisciplinary teams. She historically served as a clinical consultant and clinical research associate monitoring Phase I-IIIb trials throughout the US, Canada and Europe. Her overall work has included various drug development programs with a large pharmaceutical client where she also served as the Liaison for Quality Issues and Training. Jenny has worked extensively in a number of therapeutic areas including oncology(FAK and BRAF pathway tumors, melanoma, TNBC, ovarian, prostate), dermatology, GI, CNS (pain, depression, SAD, ADHD, Alzheimer’s Disease), CV, orthopedics, Infectious disease (HIV, Hep B, Hep C) and respiratory.
Moya Hawkins
Director of Consulting Operations
Ms. Hawkins has been in the CRO industry since 1995 managing Phase 1-4 clinical trials across both EDC and paper platforms including global, multilingual Phase 3-4 studies.
Her database experience includes serving on EDC steering committees within several companies, application validation and serving as a point person for the implementation of the transition from paper based studies to EDC studies several companies. She was an integral part of the Medrio implementation team at PharPoint Research and serves as a platform expert within the company. Ms. Hawkins’ extensive experience includes managing a multi-country, emergency use protocol, studies with special patient populations, and salvage therapy studies. Ms. Hawkins also serves on a committee and volunteers for the Society of Clinical Data Management which is a is a non-profit, international organization founded to advance the discipline of clinical data management.
Amy Flynt, PhD
Sr. Director of Consulting Operations
Dr. Flynt received her Ph.D. in statistics from North Carolina State University.
For over thirteen years, she has worked in the pharmaceutical/biomedical industry for both a CRO and a pharmaceutical company where she has served as a lead statistician and provided statistical support for Phase 1-4 clinical trials, NDA submissions, and pharmaceutical industry-sponsored pregnancy registries. She has also provided FDA representation for her sponsors, served as a DMC statistician, and as a statistical consultant. Dr. Flynt joined PharPoint Research in its inaugural year to grow the biostatistics operations. Under her leadership, the PharPoint Research biostatistics group has grown 150%.
Jayme Swinson
Executive Director of Operations
Mr. Swinson joined PharPoint Research as one of the company’s original members with the goal of establishing and leading the programming department.
He has been instrumental in defining and refining standard processes across functional areas and succeeded in orchestrating PharPoint Research’s implementation and accreditation of multiple EDC systems. He also oversees the daily operations of statistical and database programming activities. Mr. Swinson has over sixteen years of experience in the CRO industry providing both statistical analysis and clinical database programming support for Phase 1-4 clinical trials as well as patient registries. He has led multiple data standardization and warehousing projects, many of which comply with the industry accepted SDTM format. He has provided programming support and leadership for numerous NDAs, sNDA, IND safety updates and ISS/ISE analyses.
Karisa Satterly
Business Development Manager
Ms. Satterly’s eight years of experience in clinical research includes working across the biotech, pharma, device and CRO industries.
In her current role, Ms. Satterly leads initiatives for company growth and helps to diversify the company’s pipeline of work. Prior to PharPoint, Ms. Satterly held various roles of increasing responsibility in the data management industry including positions in business analytics, marketing, business development, and account management.